Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 213

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia

Open access
Litzow, Mark R., Tarima, Sergey, Pérez, Waleska S., Bolwell, Brian J., Cairo, Mitchell S., Camitta, Bruce M., Cutler, Corey S., de Lima, Marcos, DiPersio, John F., Gale, Robert Peter, Keating, Armand, Lazarus, Hillard M., Luger, Selina, Marks, David I., Maziarz, Richard T., McCarthy, Philip L., Pasquini, Marcelo C., Phillips, Gordon L., Rizzo, J. Douglas, Sierra, Jorge, Tallman, Martin S., Weisdorf, Daniel J. · 2010 · Blood

Abstract

Therapy-related myelodysplastic syndromes (t-MDSs) and acute myeloid leukemia (t-AML) have a poor prognosis with conventional therapy. Encouraging results are reported after allogeneic transplantation. We analyzed outcomes in 868 persons with t-AML (n = 545) or t-MDS (n = 323) receiving allogeneic transplants from 1990 to 2004. A myeloablative regimen was used for conditioning in 77%. Treatment-related mortality (TRM) and relapse were 41% (95% confidence interval [CI], 38-44) and 27% (24-30) at 1 year and 48% (44-51) and 31% (28-34) at 5 years, respectively. Disease-free (DFS) and overall survival (OS) were 32% (95% CI, 29-36) and 37% (34-41) at 1 year and 21% (18-24) and 22% (19-26) at 5 years, respectively. In multivariate analysis, 4 risk factors had adverse impacts on DFS and OS: (1) age older than 35 years; (2) poor-risk cytogenetics; (3) t-AML not in remission or advanced t-MDS; and (4) donor other than an HLA-identical sibling or a partially or well-matched unrelated donor. Five-year survival for subjects with none, 1, 2, 3, or 4 of these risk factors was 50% (95% CI, 38-61), 26% (20-31), 21% (16-26), 10% (5-15), and 4% (0-16), respectively (P < .001). These data permit a more precise prediction of outcome and identify subjects most likely to benefit from allogeneic transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2009-10-249128

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 213

Metadata

Authors
Litzow, M. R., Tarima, S., Pérez, W. S., Bolwell, B. J., Cairo, M. S., Camitta, B. M., Cutler, C. S., de Lima, M., DiPersio, J. F., Gale, R. P., Keating, A., Lazarus, H. M., Luger, S., Marks, D. I., Maziarz, R. T., McCarthy, P. L., Pasquini, M. C., Phillips, G. L., Rizzo, J. D., Sierra, J., Tallman, M. S., & Weisdorf, D. J.
Venue
Blood
Published
2010-03-04
Volume
115
Issue
9
Pages
1850-1857
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2160820093
Cited by
213
References
2
FWCI
9.31
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. https://app.cochat.ai/papers/10.1182/blood-2009-10-249128
The paper
Litzow, M. R., Tarima, S., Pérez, W. S., Bolwell, B. J., Cairo, M. S., Camitta, B. M., Cutler, C. S., de Lima, M., DiPersio, J. F., Gale, R. P., Keating, A., Lazarus, H. M., Luger, S., Marks, D. I., Maziarz, R. T., McCarthy, P. L., Pasquini, M. C., Phillips, G. L., Rizzo, J. D., . . . Weisdorf, D. J. (2010). Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. https://doi.org/10.1182/blood-2009-10-249128

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.